Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF

Valeria Muller, V Müller, Igor Yu. Kogan, Igor Kogan, Maria I. Yarmolinskaya, Maria Yarmolinskaya, Dariko A. Niauri, Dariko Niauri, Alexandr Gzgzyan, Edward Aylamazyan
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2017 · vol. 33(sup1) , pp. 18–21 · doi:10.1080/09513590.2017.1415676 · PMID:29264985 · W2777137090
article OA: hybrid CC0 ⤵ 48 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher

Abstract

BACKGROUND: Severe forms of genital endometriosis are known to be associated with infertility and its subsequent treatment failure. Both gonadotropin-releasing hormone analogs (a-GnRH) and dienogest have been suggested as additional hormone therapy for patients with endometriomas. However, the result of hormonal suppression before an in vitro fertilization (IVF) cycle remains undetermined. MATERIALS AND METHODS: A prospective cohort study of 144 infertile women planning IVF after laparoscopic surgery of ovarian endometriomas was conducted at our department in 2012-2015. Patients were divided into three groups: group I (N = 38) with dienogest course, group II (N = 70) with a-GnRH group III (N = 70) without any hormonal therapy within 6 months preceding IVF. RESULTS: The study groups did not differ by removed endometriomas size and ovarian reserve indicators. The gonadotropin dose per Cycle was higher, while the number of retrieved oocytes was lower in group III patients (p < .001). In women with dienogest pretreatment, clinical pregnancy rate was 2.5 times (44.7% versus 16.7%, p = .012) and delivery rate - three times higher (36.8% versus 11.1%, p = .013) as compared with those from group III. CONCLUSIONS: The present study confirms the necessity of pre-cycle medical interventions in women with ovarian forms of endometriosis undergoing IVF. We suggest dienogest to be possibly more efficient treatment option for this kind of patients.

My notes (saved in your browser only)

Condition tags

endometriosisendometriomainfertility

MeSH descriptors

Endometriosis Fertilization in Vitro Hormone Antagonists Infertility, Female Nandrolone Ovarian Diseases Adult Endometriosis Endometriosis Female Fertilization in Vitro Hormone Antagonists Humans Infertility, Female Infertility, Female Nandrolone Nandrolone Ovarian Diseases Ovarian Diseases Ovulation Induction

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (11)

Cited by (48)

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:20:07.505861+00:00
License: CC0 · commercial use OK